Mason Pharmaceutical Analysis Holdings LLC Rockville, MD - 20850

Mason Pharmaceutical Analysis Holdings LLC is categorized under in Rockville, MD and active since 2010.

Mason Pharmaceutical Analysis Holdings LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 551112 by the NAICS.

If you are seeking more information, feel free to contact Geoffrey Mason at the company’s single location by writing to 407 Grand Champion Drive, Rockville, Maryland MD 20850 or by phoning (240) 632-2335. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mason Pharmaceutical Analysis Holdings LLC
Contact Person: Geoffrey Mason
Address: 407 Grand Champion Drive, Rockville, Maryland 20850
Phone Number: (240) 632-2335
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category:
SIC Code: 6719
NAICS Code: 551112
Share This Business:

Mason Pharmaceutical Analysis Holdings LLC was started in 2010 to provide professional under the SIC code 6719 and NAICS code 551112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Geoffrey Mason for inquiries that concern Mason Pharmaceutical Analysis Holdings LLC by calling the company number (240) 632-2335, as your correspondence is most welcome. Additionally, the physical location of the single location of Mason Pharmaceutical Analysis Holdings LLC can be found at the coordinates 39.112054,-77.16613 as well as the street address 407 Grand Champion Drive in Rockville, Maryland 20850.

For its online presence, you may visit Mason Pharmaceutical Analysis Holdings LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.